RankingsPricing
  1. JP-listed companies
  2. Takeda Pharmaceutical Company Limited
  3. Financials
  4. Cash from financing

Takeda Pharmaceutical Company Limited【JP:4502】

Market cap
¥8.08T
P/E ratio
52.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from financing (Million JPY)YoY (%)
Mar 31, 2025-751,425+112.02%
Mar 31, 2024-354,416-50.02%
Mar 31, 2023-709,148-33.74%
Mar 31, 2022-1,070,265-1.66%
Mar 31, 2021-1,088,354+8.27%
Mar 31, 2020-1,005,213-134.12%
Mar 31, 20192,946,237-1003.13%
Mar 31, 2018-326,226-212.53%
Mar 31, 2017289,896-332.22%
Mar 31, 2016-124,839-58.52%
Mar 31, 2015-300,998-411.91%
Mar 31, 201496,502-162.08%
Mar 31, 2013-155,442

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)